Krystal Biotech, Inc. (KRYS)
NASDAQ·Healthcare·Biotechnology
$362.82
-0.46%
Mkt Cap $9.88B
Analyst Ratings
Buy
14
Hold
0
Sell
0
Price Target (14 analysts)
$336.40
Range $300.00 – $371.00
Implied Upside
-7.3%
Consensus $336.40 vs current $362.82
NASDAQ·Healthcare·Biotechnology
$362.82
-0.46%
Mkt Cap $9.88B
Buy
14
Hold
0
Sell
0
Price Target (14 analysts)
$336.40
Range $300.00 – $371.00
-7.3%
Consensus $336.40 vs current $362.82